A review conducted to explore the anti-cancer properties of pomegranate has found sufficient evidence that supports its use for the prevention of certain cancers.
The review looked at cell culture and animal studies, as well as human clinical trials on the use of pomegranate against certain types of cancers. After compiling and analyzing all the data, the team confirmed that pomegranate could help reduce the risk of breast, prostate, lung, colon and skin cancers, as well as hepatocellular carcinoma.
According to the review, pomegranates are good sources of antioxidants, phenolic acids and flavonoids. Just the peel of the fruit is rich in ellagitannins, ellagic acid, gallic acid, hydroxybenzoic acids and punicalagin.
The researchers said these compounds contribute to the plant’s anti-inflammatory, anti-proliferative, antioxidant and anti-tumorigenic properties. The team added that in the studies they’ve analyzed, pomegranates were able to modulate multiple signaling pathways used by cancer cells. Read more…
